Elevation of serum C-reactive protein predicts failure of the initial antimicrobial treatment for febrile neutropenia with lung cancer

Takemasa Matsumoto, Masaki Fujita, Takako Hirota, Satoshi Takeda, Ryousuke Hirano, Junji Uchino, Taishi Harada, Kentaro Watanabe

Research output: Contribution to journalArticle

Abstract

Febrile neutropenia frequently develops after chemotherapy, and the prompt administration of antimicrobial agents is required for treatment. In the present study, we searched for predictive factors for the failure of the initial antimicrobial agents used for febrile neutropenia (FN) in patients with lung cancer. Sixty FN patients treated in our ward from June 2005 to May 2011 were retrospectively analyzed. The definition of FN and the response to antimicrobial agents were determined by the Japanese guidelines. We divided the FN patients into two groups by their response to the initial antimicrobial agents. Next, the characteristics of the two groups were compared. The Multinational Association of Supportive Care in Cancer (MASCC) score did not differ between the two groups. The non-responder group demonstrated significant elevation of serum C-reactive protein (CRP) level. A multivariate analysis demonstrated that a CRP level higher than 10 mg/dl is an independent risk factor for the failure of initial antimicrobial agents for FN with lung cancer (OR 11.0, 95 % CI 1.635-74.5). When the CRP score was added to the MASCC score, the scoring system could more precisely predict the failure of initial antimicrobial agents in patients with lung cancer who developed febrile neutropenia.

Original languageEnglish
Pages (from-to)202-207
Number of pages6
JournalJournal of Infection and Chemotherapy
Volume19
Issue number2
DOIs
Publication statusPublished - Apr 2013

Fingerprint

Febrile Neutropenia
C-Reactive Protein
Anti-Infective Agents
Blood Proteins
Lung Neoplasms
Therapeutics
Neoplasms
Multivariate Analysis
Guidelines
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Elevation of serum C-reactive protein predicts failure of the initial antimicrobial treatment for febrile neutropenia with lung cancer. / Matsumoto, Takemasa; Fujita, Masaki; Hirota, Takako; Takeda, Satoshi; Hirano, Ryousuke; Uchino, Junji; Harada, Taishi; Watanabe, Kentaro.

In: Journal of Infection and Chemotherapy, Vol. 19, No. 2, 04.2013, p. 202-207.

Research output: Contribution to journalArticle

Matsumoto, Takemasa ; Fujita, Masaki ; Hirota, Takako ; Takeda, Satoshi ; Hirano, Ryousuke ; Uchino, Junji ; Harada, Taishi ; Watanabe, Kentaro. / Elevation of serum C-reactive protein predicts failure of the initial antimicrobial treatment for febrile neutropenia with lung cancer. In: Journal of Infection and Chemotherapy. 2013 ; Vol. 19, No. 2. pp. 202-207.
@article{f42bb8d7052e4b0fa474236616a4b1a0,
title = "Elevation of serum C-reactive protein predicts failure of the initial antimicrobial treatment for febrile neutropenia with lung cancer",
abstract = "Febrile neutropenia frequently develops after chemotherapy, and the prompt administration of antimicrobial agents is required for treatment. In the present study, we searched for predictive factors for the failure of the initial antimicrobial agents used for febrile neutropenia (FN) in patients with lung cancer. Sixty FN patients treated in our ward from June 2005 to May 2011 were retrospectively analyzed. The definition of FN and the response to antimicrobial agents were determined by the Japanese guidelines. We divided the FN patients into two groups by their response to the initial antimicrobial agents. Next, the characteristics of the two groups were compared. The Multinational Association of Supportive Care in Cancer (MASCC) score did not differ between the two groups. The non-responder group demonstrated significant elevation of serum C-reactive protein (CRP) level. A multivariate analysis demonstrated that a CRP level higher than 10 mg/dl is an independent risk factor for the failure of initial antimicrobial agents for FN with lung cancer (OR 11.0, 95 {\%} CI 1.635-74.5). When the CRP score was added to the MASCC score, the scoring system could more precisely predict the failure of initial antimicrobial agents in patients with lung cancer who developed febrile neutropenia.",
author = "Takemasa Matsumoto and Masaki Fujita and Takako Hirota and Satoshi Takeda and Ryousuke Hirano and Junji Uchino and Taishi Harada and Kentaro Watanabe",
year = "2013",
month = "4",
doi = "10.1007/s10156-012-0474-8",
language = "English",
volume = "19",
pages = "202--207",
journal = "Journal of Infection and Chemotherapy",
issn = "1341-321X",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Elevation of serum C-reactive protein predicts failure of the initial antimicrobial treatment for febrile neutropenia with lung cancer

AU - Matsumoto, Takemasa

AU - Fujita, Masaki

AU - Hirota, Takako

AU - Takeda, Satoshi

AU - Hirano, Ryousuke

AU - Uchino, Junji

AU - Harada, Taishi

AU - Watanabe, Kentaro

PY - 2013/4

Y1 - 2013/4

N2 - Febrile neutropenia frequently develops after chemotherapy, and the prompt administration of antimicrobial agents is required for treatment. In the present study, we searched for predictive factors for the failure of the initial antimicrobial agents used for febrile neutropenia (FN) in patients with lung cancer. Sixty FN patients treated in our ward from June 2005 to May 2011 were retrospectively analyzed. The definition of FN and the response to antimicrobial agents were determined by the Japanese guidelines. We divided the FN patients into two groups by their response to the initial antimicrobial agents. Next, the characteristics of the two groups were compared. The Multinational Association of Supportive Care in Cancer (MASCC) score did not differ between the two groups. The non-responder group demonstrated significant elevation of serum C-reactive protein (CRP) level. A multivariate analysis demonstrated that a CRP level higher than 10 mg/dl is an independent risk factor for the failure of initial antimicrobial agents for FN with lung cancer (OR 11.0, 95 % CI 1.635-74.5). When the CRP score was added to the MASCC score, the scoring system could more precisely predict the failure of initial antimicrobial agents in patients with lung cancer who developed febrile neutropenia.

AB - Febrile neutropenia frequently develops after chemotherapy, and the prompt administration of antimicrobial agents is required for treatment. In the present study, we searched for predictive factors for the failure of the initial antimicrobial agents used for febrile neutropenia (FN) in patients with lung cancer. Sixty FN patients treated in our ward from June 2005 to May 2011 were retrospectively analyzed. The definition of FN and the response to antimicrobial agents were determined by the Japanese guidelines. We divided the FN patients into two groups by their response to the initial antimicrobial agents. Next, the characteristics of the two groups were compared. The Multinational Association of Supportive Care in Cancer (MASCC) score did not differ between the two groups. The non-responder group demonstrated significant elevation of serum C-reactive protein (CRP) level. A multivariate analysis demonstrated that a CRP level higher than 10 mg/dl is an independent risk factor for the failure of initial antimicrobial agents for FN with lung cancer (OR 11.0, 95 % CI 1.635-74.5). When the CRP score was added to the MASCC score, the scoring system could more precisely predict the failure of initial antimicrobial agents in patients with lung cancer who developed febrile neutropenia.

UR - http://www.scopus.com/inward/record.url?scp=84880698294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880698294&partnerID=8YFLogxK

U2 - 10.1007/s10156-012-0474-8

DO - 10.1007/s10156-012-0474-8

M3 - Article

C2 - 23053498

AN - SCOPUS:84880698294

VL - 19

SP - 202

EP - 207

JO - Journal of Infection and Chemotherapy

JF - Journal of Infection and Chemotherapy

SN - 1341-321X

IS - 2

ER -